{
    "clinical_study": {
        "@rank": "141076", 
        "acronym": "FingoHRV", 
        "brief_summary": {
            "textblock": "The purpose of this study is to study the effect of fingolimod on cardiac autonomic\n      regulation in patients with relapse-remitting multiple sclerosis.\n\n      This will be done by measuring heart rate variability from the 24-hour Holter recording and\n      myocardial ventricular repolarisation patterns from the 12-lead electrocardiogram tracings.\n\n      The fingolimod treatment is prescribed according to the accepted drug label."
        }, 
        "brief_title": "Effect of Fingolimod on the Cardiac Autonomic Regulation in Patients With Multiple Sclerosis", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "condition": "Relapse-remitting Multiple Sclerosis", 
        "condition_browse": {
            "mesh_term": [
                "Multiple Sclerosis", 
                "Sclerosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "The study will include 30 relapse-remitting multiple sclerosis patients. Assessments of\n      heart rate variability and myocardial ventricular repolarisation pattern will be done 1)\n      before fingolimod, 2) first day of fingolimod 3) after 3 months use and 4) after 12 months\n      use of fingolimod."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 18 - 65 years\n\n          -  Understands the proposed research and actions to be taken\n\n          -  The written informed consent has given\n\n          -  clinical indication to fingolimod-treatment\n\n        Exclusion Criteria:\n\n          -  Patient refuses\n\n          -  Patient takes or has taken part in other clinical drug trial during the last month\n\n          -  No clinical indication to the use of fingolimod\n\n          -  Contraindication to the use of fingolimod"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Neurological clinic"
            }
        }, 
        "enrollment": {
            "#text": "27", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 8, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01704183", 
            "org_study_id": "IIT-2012-SS", 
            "secondary_id": "2012-002694-66"
        }, 
        "intervention_browse": {
            "mesh_term": "Fingolimod"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "relapse-remitting multiple sclerosis", 
            "heart rate variability", 
            "fingolimod", 
            "cardiac autonomic regulation"
        ], 
        "lastchanged_date": "May 7, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Kuopio", 
                        "country": "Finland"
                    }, 
                    "name": "Neuro Center, Kuopio University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mikkeli", 
                        "country": "Finland"
                    }, 
                    "name": "Department of Neurology, Mikkeli Central Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": "Finland"
        }, 
        "number_of_groups": "1", 
        "official_title": "Effect of Fingolimod on the Cardiac Autonomic Regulation in Patients With Multiple Sclerosis", 
        "overall_official": [
            {
                "affiliation": "Mikkeli Central Hospital, Department of Neurology", 
                "last_name": "Sakari Simula, MD, PhD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Kuopio University Hospital, Neuro Center", 
                "last_name": "P\u00e4ivi Hartikainen, MD, PhD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Kuopio University Hospital, Heart Center", 
                "last_name": "Juha Hartikainen, MD, PhD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Finland: Finnish Medicines Agency"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "change in heart rate variability", 
            "safety_issue": "Yes", 
            "time_frame": "prior medication vs initiation vs 3 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01704183"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Kuopio University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Kuopio University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}